An observational study in COVID-19, sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University. Active, not recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University · Observational
The purpose of this study is to explore the factors that can affect the development of severe cases in hospitalized patients with COVID-19, including basic diseases, laboratory parameters, and clinical manifestations; In addition,to explore whether Azvudine can reduce the mortality of hospitalized patients with COVID-19.
4201 COVID-19 patients discharged from our hospital were enrolled. Binary logistic regression analysis and ROC curve were used to investigate the role of comorbidities, laboratory parameters and clinical manifestation on progression of COVID-19 patients. We used propensity-score models conditional on baseline characteristics and Univariate Cox regression model to examine whether Azvudine can reduce the mortality of COVID-19 patients.
7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's planned enrollment of 4,201 is above the median of 261 across 3,136 observational studies indexed under COVID-19.
Browse COVID-19 studies →Fifth Affiliated Hospital, Sun Yat-Sen University is the lead sponsor of 57 studies on the registry; 20 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The COVID-19 positive patients
The COVID-19 positive patients
Exclusion Criteria:
Azvudine group included COVID-19 patients treated with azvudine antiviral therapy;
Drug: Azvudine
No antiviral group included COVID-19 patients treated with no antiviral therapy;
Monotamivir group included COVID-19 patients treated with monotamivir antiviral therapy
Received antiviral treatment with azvudine
All-cause mortality of COVID-19 patients
All-cause mortality of COVID-19 patients
Time frame: Time from onset to death
Plan to share: No — Publication of academic papers
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fifth Affiliated Hospital, Sun Yat-Sen University